Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.divislabs.com | |
Market Cap | 91,234.91 Cr. | |
Enterprise Value(EV) | 87,625.91 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 52.10 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 65.97 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 491.02 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 7.00 | Calculated using Price: 3,436.75 |
Dividend Yield | 0.87 | Period Ending 2023-03 |
No. of Shares Subscribed | 26.55 Cr. | 265,468,580 Shares |
FaceValue | 2 | |
About Divi's Laboratories Ltd. | ||
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. |
1 Day |
|
+2.61% |
1 Week |
|
+0.58% |
1 Month |
|
-2.41% |
3 Month |
|
-11.12% |
6 Month |
|
-8.33% |
1 Year |
|
+22.05% |
2 Year |
|
-22.53% |
5 Year |
|
+107.39% |
10 Year |
|
+415.54% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 26.37 | 28.91 | 21.98 | 15.55 | 21 | 19.3 | 23.9 | 28.16 | 14.89 | |
Return on Capital Employed (%) | 33.06 | 35.57 | 28.75 | 21.68 | 28.5 | 25.36 | 32.07 | 35.06 | 19.36 | |
Return on Assets (%) | 18.21 | 22.49 | 17.21 | 11.12 | 15.78 | 15.11 | 19.07 | 22.77 | 12.37 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3,495 | 4,293 | 5,357 | 5,925 | 6,957 | 7,310 | 9,295 | 11,728 | 12,767 | 12,677 | |
Non Curr. Liab. | 842 | 85 | 1,412 | 1,769 | 991 | 295 | 364 | 437 | 556 | 582 | |
Curr. Liab. | 776 | 520 | 659 | 653 | 847 | 1,821 | 1,728 | 2,454 | 1,533 | 1,011 | |
Minority Int. | |||||||||||
Equity & Liab. | 5,112 | 4,898 | 7,429 | 8,347 | 8,795 | 9,425 | 11,387 | 14,619 | 14,857 | 14,270 | |
Non Curr. Assets | 2,340 | 1,871 | 3,418 | 3,812 | 4,145 | 3,851 | 4,596 | 5,009 | 5,113 | 5,388 | |
Curr. Assets | 2,772 | 3,027 | 4,011 | 4,535 | 4,650 | 5,574 | 6,791 | 9,610 | 9,744 | 8,882 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5,112 | 4,898 | 7,429 | 8,347 | 8,795 | 9,425 | 11,387 | 14,619 | 14,857 | 14,270 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 3,115 | 3,776 | 4,064 | 3,891 | 4,946 | 5,394 | 6,969 | 8,960 | 7,768 | 7,493 | |
Other Income | 45 | 97 | 75 | 113 | 156 | 190 | 63 | 116 | 345 | 328 | |
Total Income | 3,160 | 3,874 | 4,139 | 4,005 | 5,102 | 5,584 | 7,032 | 9,076 | 8,112 | 7,821 | |
Total Expenditure | -1,949 | -2,358 | -2,617 | -2,629 | -3,073 | -3,571 | -4,108 | -5,079 | -5,398 | -5,533 | |
PBIDT | 1,211 | 1,516 | 1,522 | 1,376 | 2,029 | 2,013 | 2,924 | 3,997 | 2,714 | 2,288 | |
Interest | -3 | -5 | -3 | -2 | -5 | -7 | -2 | -2 | -2 | -1 | |
Depreciation | -136 | -118 | -123 | -142 | -169 | -186 | -256 | -312 | -343 | -370 | |
Taxation | -221 | -267 | -335 | -354 | -502 | -443 | -682 | -723 | -545 | -534 | |
Exceptional Items | |||||||||||
PAT | 852 | 1,126 | 1,060 | 877 | 1,353 | 1,377 | 1,984 | 2,960 | 1,823 | 1,383 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 852 | 1,126 | 1,060 | 877 | 1,353 | 1,377 | 1,984 | 2,960 | 1,823 | 1,383 | |
Adjusted EPS | 32 | 42 | 40 | 33 | 51 | 52 | 75 | 112 | 69 | 52 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 557 | 826 | 1,038 | 1,150 | 776 | 954 | 1,216 | 1,947 | 1,912 | 2,460 | |
Cash Fr. Inv. | -305 | -521 | -406 | -1,140 | -478 | -685 | -83 | 75 | -2,195 | -2,708 | |
Cash Fr. Finan. | -249 | -303 | -631 | 2 | -314 | -246 | -1,091 | -35 | -532 | -797 | |
Net Change | 3 | 3 | 0 | 13 | -17 | 23 | 41 | 1,987 | -816 | -1,045 | |
Cash & Cash Eqvt | 15 | 18 | 18 | -4 | -21 | 2 | 43 | 2,030 | 1,215 | 170 |
Tue, 05 Mar 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement relating to Postal Ballot Notice |
Mon, 04 Mar 2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Submission of Postal Ballot Notice dated February 10 2024. |
Fri, 16 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript We herewith enclose the Transcript of earnings conference call held on February 10 2024. |
Thu, 28 Mar 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Opening at Low |
Closing Above Previous High |